Trump Administration Proposes $6.8 Billion FDA Budget Cut for 2026

The Trump administration has proposed a $6.8 billion budget for the U.S. Food and Drug Administration (FDA) for fiscal year 2026, marking a 5.5% reduction from the current $7.2 billion allocation. FDA Commissioner Martin Makary emphasized that the budget supports the "Make America Healthy Again" agenda, with $3.2 billion in budget authority and $3.6 billion in user fees included. The agency has undergone significant restructuring, including nearly 1,900 layoffs and 1,200 early retirements, aiming to reduce federal government size while maintaining operational efficiency. Despite these staffing changes, no scientific reviewers or inspectors were cut, and the FDA remains on track to meet its treatment review timelines under the Prescription Drug User Fee Act. Initiatives highlighted include removing petroleum-based food dyes, ending animal testing requirements for drugs, and approving a new Alzheimer's blood test. Officials maintain that these reforms and budget cuts have not compromised the FDA's ability to carry out its mission effectively.